Correction: Influenza a virus NS1 protein inhibits the NLRP3 inflammasome (PLoS One (2015) 10:5 (e0126456) DOI: 10.1371/journal.pone.0126456);Influenza A virus NS1 protein inhibits the NLRP3 inflammasome

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Cheong, Woo Chang ^a   Kang, Hye Ri ^a   Yoon, Hyunyee ^a,b   Kang, Suk Jo ^c   Ting, Jenny P Y ^d   Song, Moon Jung ^a  

^a Korea University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; NONSTRUCTURAL PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; LIPOPOLYSACCHARIDE; NLRP3 PROTEIN, HUMAN; VIRAL PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNOMODULATION; IN VITRO STUDY; INFLUENZA VIRUS A; INHIBITION KINETICS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TRANSACTIVATION INHIBITION; TRANSCRIPTION REGULATION; VIRUS STRAIN; CELL LINE; CONFOCAL MICROSCOPY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

INFLUENZA A VIRUS;

ADENOSINE TRIPHOSPHATE; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; INFLAMMASOMES; INFLUENZA A VIRUS; INTERLEUKIN-18; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICROSCOPY, CONFOCAL; NF-KAPPA B; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84929346755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0200624     Document Type: Erratum

References (48)

1. Brodsky IE, Monack D. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin Immunol. 2009; 21(4):199-207. doi: 10.1016/j.smim.2009.05.007 PMID: 19539499
2. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009; 27:229-65. doi: 10.1146/annurev.immunol.021908.132715 PMID: 19302040
3. Pedra JH, Cassel SL, Sutterwala FS. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol. 2009; 21(1):10-6. doi: 10.1016/j.coi.2009.01.006 PMID: 19223160
4. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009; 7(2):99-109. doi: 10.1038/nrmicro2070 PMID: 19148178
5. Ting JP-Y, Willingham SB, Bergstralh DT. NLRs at the intersection of cell death and immunity. Nat Rev Immunol. 2008; 8(5):372-9. doi: 10.1038/nri2296 PMID: 18362948
6. Bryant C, Fitzgerald KA. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 2009; 19(9):455-64. doi: 10.1016/j.tcb.2009.06.002 PMID: 19716304
7. Cassel SL, Joly S, Sutterwala FS. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol. 2009; 21(4):194-8. doi: 10.1016/j.smim.2009.05.002 PMID: 19501527
8. Davis BK, Wen H, Ting JPY. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011; 29:707-35. doi: 10.1146/annurev-immunol-031210-101405 PMID: 21219188
9. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009; 10(3):241-7. doi: 10.1038/ni.1703 PMID: 19221555
10. Bortoluci KR, Medzhitov R. Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cell Mol Life Sci. 2010; 67(10):1643-51. doi: 10.1007/s00018-010-0335-5 PMID: 20229126
11. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010; 11(12):1136-42. doi: 10.1038/ni.1960 PMID: 21057511
12. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S. Virus infection activates IL-1β and IL- 18 production in human macrophages by a caspase-1-dependent pathway. J Immunol. 1999; 162- (12):7322-9. PMID: 10358182
13. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008; 3:499. PMID: 18039138
14. Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine. 2002; 20:3068-87. PMID: 12163258
15. Potter CW. A history of influenza. J Appl Microbiol. 2001; 91(4):572-9. PMID: 11576290
16. Ichinohe T, Pang IK, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol. 2010; 11(5):404-10. doi: 10.1038/ni.1861 PMID: 20383149
17. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009; 30(4):556-65. doi: 10.1016/j.immuni.2009.02.005 PMID: 19362020
18. McAuley JL, Tate MD, MacKenzie-Kludas CJ, Pinar A, Zeng W, Stutz A, et al. Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease. PLoS Pathog. 2013; 9(5):e1003392. doi: 10.1371/journal.ppat.1003392 PMID: 23737748
19. Pothlichet J, Meunier I, Davis BK, Ting JP, Skamene E, von Messling V, et al. Type I IFN Triggers RIGI/TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected Cells. PLoS pathog. 2013; 9(4):e1003256. doi: 10.1371/journal.ppat.1003256 PMID: 23592984
20. Thomas PG, Dash P, Aldridge JR Jr, Ellebedy AH, Reynolds C, Funk AJ, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 2009; 30(4):566-75. doi: 10.1016/j.immuni.2009.02.006 PMID: 19362023
21. Fernandez-Sesma A. The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Infect Disord Drug Targets. 2007; 7(4):336-43. PMID: 18220965
22. Hale BG, Randall RE, Ortín J, Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol. 2008; 89(10):2359-76. doi: 10.1099/vir.0.2008/004606-0 PMID: 18796704
23. Gack MU, Albrecht RA, Urano T, Inn K-S, Huang I, Carnero E, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009; 5(5):439-49. doi: 10.1016/j.chom.2009.04.006 PMID: 19454348
24. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, et al. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol. 2000; 74:11566-73. PMID: 11090154
25. Gao S, Song L, Li J, Zhang Z, Peng H, Jiang W, et al. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell Microbiol. 2012; 14(12):1849-66. doi: 10.1111/cmi.12005 PMID: 22891964
26. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park M-S, Yuen T, et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol. 2006; 80(13):6295-304. PMID: 16775317
27. Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, Katinger H, et al. Influenza Amutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1β and 18. J Gen Virol. 2005; 86(1):185-95.
28. Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunol. 2007; 8(1):1.
29. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocytemacrophage differentiation. Experientia. 1991; 47(1):22-31. PMID: 1999239
30. Wu NC, Young AP, Dandekar S, Wijersuriya H, Al-Mawsawi LQ, Wu T-T, et al. Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening. J Virol. 2013; 87(2):1193-9. doi: 10.1128/JVI.01658-12 PMID: 23152521
31. Kang HR, Cheong WC, Park J-E, Ryu S, Cho HJ, Youn H, et al. Murine gammaherpesvirus 68 encoding open reading frame 11 targets TANK binding kinase 1 to negatively regulate the host type I interferon response. J Virol. 2014; 88(12):6832-46. doi: 10.1128/JVI.03460-13 PMID: 24696485
32. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 1995; 92(16):7297-301. PMID: 7638184
33. Chanput W, Mes J, Vreeburg RA, Savelkoul HF, Wichers HJ. Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds. Food Funct. 2010; 1(3):254-61. doi: 10.1039/c0fo00113a PMID: 21776474
34. Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, Goodbourn S, et al. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-β pathway. Virology. 2006; 347(1):52-64. PMID: 16378631
35. Kochs G, García-Sastre A, Martínez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol. 2007; 81(13):7011-21. PMID: 17442719
36. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA. 1999; 5(2):195-205. PMID: 10024172
37. Forbes NE, Ping J, Dankar SK, Jia JJ, Selman M, Keleta L, et al. Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse. PLoS One. 2012; 7(2):e31839. doi: 10.1371/journal.pone.0031839 PMID: 22363747
38. Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, et al. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol. 2010; 84(14):6909-22. doi: 10.1128/JVI.00081-10 PMID: 20444891
39. Noah DL, Twu KY, Krug RM. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 30 end processing of cellular pre-mRNAS. Virology. 2003; 307(2):386-95. PMID: 12667806
40. Li Y, Chen Z-Y, Wang W, Baker CC, Krug RM. The 30-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA. 2001; 7(06):920-31.
41. Garciá-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 1998; 252(2):324-30. PMID: 9878611
42. Mibayashi M, Martínez-Sobrido L, Loo YM, Cárdenas WB, Gale M, García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol. 2007; 81(2):514-24. PMID: 17079289
43. Li Y, Yamakita Y, Krug RM. Regulation of a nuclear export signal by an adjacent inhibitory sequence: The effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci U S A. 1998; 95(9):4864-9. PMID: 9560194
44. Melen K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, Krug RM, et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol. 2007; 81- (11):5995-6006. PMID: 17376915
45. Cassel SL, Joly S, Sutterwala FS, editors. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol; 2009; 21(4):194-198 doi: 10.1016/j.smim.2009.05.002 PMID: 19501527
46. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 30 end formation of cellular pre-mRNAs. Mol Cell. 1998; 1- (7):991-1000. PMID: 9651582
47. Qiu Y, Krug RM. The influenza virus NS1 protein is a poly (A)-binding protein that inhibits nuclear export of mRNAs containing poly (A). J Virol. 1994; 68(4):2425-32. PMID: 7908060
48. Chua MA, Schmid S, Perez JT, Langlois RA, tenOever BR. Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Rep. 2013; 3(1):23-9. doi: 10.1016/j.celrep.2012.12.010 PMID: 23333274